GSK Posts Positive Phase III Gonorrhea Results for Antibiotic Gepotidacin
Zydus' Generic Azithromycin Receives Approval in the U.S.
Zudus' Generic Azithromycin Receives Approval in the U.S.
Ahmedabad: The fresh outbreak of Covid-19 in China has spurred an increase in the prices of active pharma ingredients - the components used to manufacture drugs - for Covid medicines like paracetamol, azithromycin and others.
India's pharmaceutical industry, which is dependent on China for active pharmaceutical ingredients (APIs), intermediates and bulk drugs, has been hit by the Covid-19 surge in that country. Key APIs have become 12-25% costlier in the past few days amid possible supply disruptions that may squeeze margins and raise drug prices, industry executives said. This could also lead to drug shortages, they warned.
Yung Shin Pharma's Generic Azithromycin Receives Approval in the U.S.
ACI's Generic Azithromycin Receives Approval In U.S
ACI's Generic Azithromycin Receives Approval In US
Enforcement Report - Week of June 15, 2022